HDGFL2 and malaria: Malaria control in the context of emerging drug resistance k13 mutations is compounded by additional challenges such as seasonal malaria transmission, population mobility, recent conflict, and the growing prevalence of hrp2/3 gene deletions, which compromise the effectiveness of widely used rapid diagnostic tests [26–28].